Overall, with respect to cultured cell lines, animal tumor‐bearing models, and clinical human samples, we revealed that USP52 controlled the sensitivity of tumor cells to ferroptosis by stabilizing the xCT protein in a deubiquitinase‐dependent manner, which consequently facilitated BLCA progression. The gene discussed is SLC7A11; the disease is bladder transitional cell carcinoma.